GRAFTSKIN

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1994-2017
012319942017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
BACKGROUND Biofilms are aggregations of microorganisms that have been identified as potential pathogens in the chronicity of… (More)
Is this relevant?
2003
2003
BACKGROUND Epidermolysis bullosa (EB) is a family of 23 genetic skin disorders for which treatments are mainly supportive… (More)
Is this relevant?
2002
2002
A relatively recent option for treating leg ulcers that have lasted longer than a month is to use living bilayered skin… (More)
Is this relevant?
2002
2002
BACKGROUND Chronic diabetes-related foot ulcers result from predisposition, tissue injury, and inadequate reparative mechanisms… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
OBJECTIVE We assessed in a randomized prospective trial the effectiveness of Graftskin, a living skin equivalent, in treating… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
2000
2000
Several recent advances in wound care may offer promise for the treatment of hard-to-heal venous leg ulcers. One such treatment… (More)
Is this relevant?
2000
2000
Tissue-engineering products can cover wounds and provide a microenvironment that stimulates their repair. To date, Graftskin… (More)
Is this relevant?
Highly Cited
1999
Highly Cited
1999
The efficacy of a bilayered, living skin construct (APLIGRAF(R) [Graftskin]) was evaluated in patients (n = 120) with hard- to… (More)
Is this relevant?
1995
1995
BACKGROUND Bioengineered skin substitutes offer tissue replacement without requiring a donor site and might produce better… (More)
Is this relevant?
1994
1994
We used a living bilayered cultured skin replacement to close full-thickness wound defects on the dorsum of athymic mice. The… (More)
Is this relevant?